Novavax, Inc. Price Today
Novavax, Inc.
NVAX
Healthcare
$695.62M
💰
Market Cap
0
💸
Price to Earnings
$-14.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
1 |
Strong Buy |
1 |
Hold |
5 |
Sell |
3 |
Strong Sell |
2 |
NVAX Price Forecast Target
8.1 👉 41.0 +409%
NVAX EPS Forecast
-14.9 👉 -1.8 +-88%
Financials
Profit Margin
-85 %
Revenue Growth
-88.5 %
Dividend
$ 0
Held Percent
0.6% - Insiders
70.6% - Institutions
28.8% - Public
Major Fund Holders
-
💰 State Street Corporation $76.9M
-
💰 Vanguard Group Inc $70.6M
-
💰 Shah Capital Management $40.7M
-
💰 Blackrock Inc. $33.1M
-
💰 Renaissance Technologies, LLC $24.5M
Stock Ideas
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…📮FAQ
Some Frequently Asked Questions.
The Novavax, Inc. industry is Biotechnology
The Novavax, Inc. sector is Healthcare
The Novavax, Inc. forecasted predicted Price to Earnings PE ratio is -4.5
The Novavax, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Novavax, Inc. is $695.62M
There are total of 80418215 float shares with 70.6% held by Institutions and 0.6% held by insiders
The MNovavax, Inc. forecasted Earnings per Share EPS is $-1.8
The Novavax, Inc. Earnings per Share EPS is -14.9
The Novavax, Inc. company has $-156045000 gross profits with -85 profit margins
The Novavax, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Novavax, Inc. Revenue is $1358851968 with -0.885 revenue growth
The price target for Novavax, Inc. stock is $41.0 for the high target and $9.0 for the low target
The consensus analyst recommendations for Novavax, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Novavax, Inc. is Hold, with the following breakdown:
- Buy: 1
- Strong Buy: 1
- Hold: 5
- Sell: 3
- Strong Sell: 2
The Beta of Novavax, Inc. is 1.7
The dividend of Novavax, Inc. is $0
The dividend yield of Novavax, Inc. is 0%
The biggest institutional and mutual fund holders of Novavax, Inc. stock are
- State Street Corporation
- Vanguard Group Inc
- Shah Capital Management
- Blackrock Inc.
The Novavax, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0